In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

In a 72-week study, Zepbound's mean weight loss was 20.2%, while Wegovy's was 13.7% ... Second, the medicine everyone thought would take over the industry, Novo Nordisk's CagriSema, did not ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.